Results 171 to 180 of about 3,657 (192)

Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis

Frontiers in Microbiology, 2021
Ebrahim Kouhsari, Zahra Farshadzadeh, Mehdi Goudarzi   +2 more
exaly  

An Experience with Delamanid in an XDR TB Case – Case Report

Infectious Disorders - Drug Targets, 2021
Lipika Singhal
exaly  

Bedaquiline/delamanid

Reactions Weekly, 2017
openaire   +1 more source

Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging

Drug Development Research, 2019
Wenhong Zhang, Wenhong Zhang
exaly  

Progress of Delamanid in the Treatment of Tuberculosis

2022 International Conference on Biotechnology, Life Science and Medical Engineering (BLSME 2022), 2022
openaire   +1 more source

Delamanid Kills Dormant Mycobacteria In Vitro and in a Guinea Pig Model of Tuberculosis

Antimicrobial Agents and Chemotherapy, 2017
Erina Hanaki, Izuru Nakamura
exaly  

Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis

Antimicrobial Agents and Chemotherapy, 2020
Suresh Mallikaarjun
exaly  

Delamanid Does Not Inhibit or Induce Cytochrome P450 Enzymes <i>in Vitro</i>

Biological and Pharmaceutical Bulletin, 2014
Sasahara Katsunori, Ken Umehara, Yoshihiko Shimokawa   +2 more
exaly  

Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis

Clinical Infectious Diseases, 2020
Palwasha Yousafzai Khan, Carole Mitnick, Molly Franke   +2 more
exaly  

Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)

Tuberculosis, 2018
Yongge Liu, Lawrence Geiter
exaly